Atlas Trials

Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery

Clinical trial NCT01234935 · COMPLETED

Trial details

NCT number
NCT01234935
Sponsor
Translational Oncology Research International
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IA Pancreatic CancerStage IB Pancreatic CancerStage IIA Pancreatic CancerStage IIB Pancreatic CancerStage III Pancreatic Cancer
Start date
2011-01-13
Primary completion
2017-11-27
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.